Benjamin BENEUX SRL
Benjamin BENEUX reported total assets of €1.28m at the end of the 2025 financial year (annual accounts filed with the NBB on 02 Jun 2026).
The score of Benjamin BENEUX shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +190 % Total assets +21 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Benjamin BENEUX's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 02 Jun 2026
- Year ended 31 Dec 2024filed on 27 Jun 2025
- Year ended 31 Dec 2023filed on 20 Jun 2024
- Year ended 31 Dec 2022filed on 20 Jul 2023
- Year ended 31 Dec 2021filed on 01 Aug 2022
Benjamin BENEUX's financial analysis
- Solvency34.4%sector median: 40.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Benjamin BENEUX
Benjamin BENEUX's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0743.951.495
- VAT number
- BE0743951495
- Peppol
- Registered · 0208:0743951495 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 21 Feb 2020
- Registered office
- 4432 Ans
- Latest accounts
- 2025 · filed on 02 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Benjamin BENEUX (SRL) has been based in Ans since 2020, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 143,455 € and equity of 440,923 €; its revenue is not published. Its solvency stands at 34.4%, below the median of its sector (40.1%).
Companies similar to Benjamin BENEUX
Companies in the same business, of comparable size and area, outside its group.
- Decopharma Retail sale of pharmaceutical products Sint-Niklaas · balance sheet €1.36m
- DE Spiegeleere - Discart Retail sale of pharmaceutical products Braine-l'Alleud · balance sheet €1.36m
- Pharmacie DE Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- Neveux Retail sale of pharmaceutical products Sint-Niklaas · balance sheet €1.29m
- Apotheek Sevens Retail sale of pharmaceutical products Lommel · balance sheet €1.27m
- HM Pharma Retail sale of pharmaceutical products Pittem · balance sheet €1.25m
- Alba2RO Retail sale of pharmaceutical products Gembloux · balance sheet €1.25m
- Ritzen Anouk Retail sale of pharmaceutical products Keerbergen · balance sheet €1.25m
Frequently asked questions about Benjamin BENEUX
What is the revenue of Benjamin BENEUX?
Benjamin BENEUX files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Benjamin BENEUX?
In Belgium, the VAT number is the company number prefixed with BE: BE0743951495 for Benjamin BENEUX, if the company is VAT-registered. Its company number (CBE) is 0743.951.495.
Where is the registered office of Benjamin BENEUX?
According to the CBE register, the registered office of Benjamin BENEUX is in 4432 Ans.
What is the equity of Benjamin BENEUX?
At the close of the 2025 financial year, the equity of Benjamin BENEUX amounts to 440,923 €, a solvency of 34.4% of total assets.
Who manages Benjamin BENEUX?
The register lists 1 active mandates at Benjamin BENEUX. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Benjamin BENEUX
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →